ArticlePloS one2022

Metronomic doses and drug schematic combination response tested within chambered coverslips for the treatment of breast cancer cells (JIMT-1).

Gustavo Rosero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.